Recent XLRN Analyst Ratings Breakdown, Making XLRN Stock Predictions
1 Mo. Ago
2 Mo. Ago
3 Mo. Ago
Strong buy ratings:
Strong sell ratings:
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.
For the XLRN stock predictions from the analysts covering Acceleron Pharma, Inc., we have collected all of the individual XLRN stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the different analysts covering XLRN (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since XLRN stock predictions may vary widely, another useful metric to consider is the medianXLRN stock prediction, which represents the price at which half of the analysts
made XLRN stock predictions that were higher and half made XLRN stock predictions that were lower. This makes for a different take on the XLRN stock predictions out there, as compared to average or mean.
And that median across all the individual XLRN stock predictions was: $ as of .
Nothing in this site or parent site DividendChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.